X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC LTD ELDER PHARMA/
ALEMBIC LTD
 
P/E (TTM) x -0.2 75.7 - View Chart
P/BV x 0.1 2.8 3.6% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ELDER PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC LTD
Mar-16
ELDER PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs38053 719.7%   
Low Rs18829 641.6%   
Sales per share (Unadj.) Rs491.24.7 10,407.3%  
Earnings per share (Unadj.) Rs-3.28.8 -36.3%  
Cash flow per share (Unadj.) Rs14.49.0 160.0%  
Dividends per share (Unadj.) Rs00.15 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.527.7 1,357.9%  
Shares outstanding (eoy) m20.54267.03 7.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.68.7 6.6%   
Avg P/E ratio x-89.34.7 -1,907.8%  
P/CF ratio (eoy) x19.74.6 432.3%  
Price / Book Value ratio x0.81.5 50.9%  
Dividend payout %01.7 0.0%   
Avg Mkt Cap Rs m5,83310,962 53.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,179238 915.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0891,260 800.5%  
Other income Rs m257264 97.3%   
Total revenues Rs m10,3461,524 678.8%   
Gross profit Rs m-79283 -956.4%  
Depreciation Rs m36161 588.4%   
Interest Rs m2,7560 918,766.7%   
Profit before tax Rs m-3,653285 -1,282.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m3,713-32 -11,530.1%   
Tax Rs m1256 2,051.6%   
Profit after tax Rs m-652,343 -2.8%  
Gross profit margin %-7.86.6 -119.5%  
Effective tax rate %-3.42.1 -160.0%   
Net profit margin %-0.6185.9 -0.3%  
BALANCE SHEET DATA
Current assets Rs m9,2401,689 547.1%   
Current liabilities Rs m9,998486 2,056.3%   
Net working cap to sales %-7.595.4 -7.9%  
Current ratio x0.93.5 26.6%  
Inventory Days Days46217 21.3%  
Debtors Days Days6081 74.0%  
Net fixed assets Rs m10,1241,624 623.3%   
Share capital Rs m206534 38.5%   
"Free" reserves Rs m5,5825,960 93.7%   
Net worth Rs m7,7347,404 104.5%   
Long term debt Rs m4,889104 4,687.4%   
Total assets Rs m22,8828,010 285.7%  
Interest coverage x-0.3950.7 -0.0%   
Debt to equity ratio x0.60 4,487.7%  
Sales to assets ratio x0.40.2 280.2%   
Return on assets %11.829.3 40.2%  
Return on equity %-0.831.6 -2.7%  
Return on capital %22.331.3 71.3%  
Exports to sales %3.02.9 103.2%   
Imports to sales %0.428.9 1.5%   
Exports (fob) Rs m30737 826.4%   
Imports (cif) Rs m43364 11.9%   
Fx inflow Rs m30737 826.4%   
Fx outflow Rs m125365 34.3%   
Net fx Rs m181-328 -55.3%   
CASH FLOW
From Operations Rs m11,754346 3,401.1%  
From Investments Rs m-561-48 1,177.5%  
From Financial Activity Rs m-6,762-301 2,246.4%  
Net Cashflow Rs m4,432-3 -147,723.3%  

Share Holding

Indian Promoters % 39.6 64.0 61.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 16.8 9.7 173.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.1 138.3%  
Shareholders   16,479 54,701 30.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS